Literature DB >> 11403997

The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors.

R Pawlak1, D Napiorkowska-Pawlak, Y Takada, T Urano, N Nagai, H Ihara, A Takada.   

Abstract

Angiotensin 1-7 has been recently claimed the active member of the angiotensins' family. In the present study we compared the effect of angiotensin II and angiotensin 1-7 on the concentration of dopamine, serotonin, epinephrine, and norepinephrine and some of their metabolites in the rat hypothalamus, where the levels of angiotensins are particularly high. Intracerebroventricular injection of angiotensin II, but not angiotensin 1-7, time-dependently elevated the levels of both epinephrine (p < 0.05) and norepinephrine (p < 0.05) in the hypothalamus and both effects could be prevented by intracerebroventricular injection of either AT(1) (candesartan), AT(2) (PD123319) or AT(1-7) (A-779) receptor antagonist. Neither angiotensin II nor angiotensin 1-7 produced any changes in the level of dopamine, dihydroxyphenylacetic acid, homovanilic acid, serotonin, 5-hydroxyindoleacetic acid, or tryptophan at any time point in comparison with the control groups. However, AT(1) but not AT(2) receptor blockade, unmasked the stimulatory effect of angiotensin 1-7 on dopamine concentration in the hypothalamus. Thus, angiotensin II and its active metabolite angiotensin 1-7 regulate selectively, albeit differentially, adrenergic, noradrenergic and dopaminergic systems in the hypothalamus, the effects that involve AT(1), AT(2) and AT(1-7) angiotensin receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403997     DOI: 10.1016/s0361-9230(01)00489-0

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  Spinophilin regulates central angiotensin II-mediated effect on blood pressure.

Authors:  Andrey C da Costa Goncalves; Marco Antonio Peliky Fontes; Enno Klussmann; Fatimunnisa Qadri; Jürgen Janke; Maik Gollasch; Johanna Schleifenbaum; Dominik Müller; Jens Jordan; Jens Tank; Friedrich C Luft; Volkmar Gross
Journal:  J Mol Med (Berl)       Date:  2011-08-05       Impact factor: 4.599

Review 2.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

3.  Kidney dopamine D1-like receptors and angiotensin 1-7 interaction inhibits renal Na+ transporters.

Authors:  Anees A Banday; Andrea Diaz Diaz; Mustafa Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-14

Review 4.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 5.  Diagnostic tools for hypertension and salt sensitivity testing.

Authors:  Robin A Felder; Marquitta J White; Scott M Williams; Pedro A Jose
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-01       Impact factor: 2.894

6.  Cognitive benefits of angiotensin IV and angiotensin-(1-7): A systematic review of experimental studies.

Authors:  Jean K Ho; Daniel A Nation
Journal:  Neurosci Biobehav Rev       Date:  2018-05-04       Impact factor: 8.989

7.  SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies.

Authors:  Mary G Hornick; Margaret E Olson; Arun L Jadhav
Journal:  Int J Neuropsychopharmacol       Date:  2022-01-12       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.